| Decision | Consent Granted Section 13(1)(a) Overseas Investment Act 2005 |
|---|---|
| Decision date | 12 August 2010 |
| Investment | An overseas investment in significant business assets, being the Applicant's acquisition of rights or interests in 100.0% of the shares of Healthscope Limited, the value of the assets of Healthscope Limited and its 25% or more subsidiaries being greater than $100m. |
| Asset Value | $101,168,378 |
| Applicant | Asia Pacific Healthcare Group Pty Limited TPG Capital L.P., United States of America (50.0%) The Carlyle Group, United States of America (50.0%) |
| Vendor | Existing shareholders of Healthscope Limited Various overseas persons (45.3%) National Nominees Limited, Australia (16.98%) JP Morgan Nominees Australia Limited, Australia (12.45%) HSBC Custody Nominees Limited, Australia (10.3%) Cogent Nominees Pty Limited, Australia (3.57%) Citigroup Nominees Pty Limited, Australia (3.57%) ANZ Nominees Limited, Australia (3.08%) Tasman Asset Management, Australia (2.58%) RBC Dexia Investor Services Australia Nominees Pty Limited, Australia (2.17%) |
| Background | Healthscope is a leading private health care provider in Australia, operating 44 private hospitals throughout Australia. The Healthscope group operates in New Zealand through Healthscope New Zealand Limited and is a leading provider of pathology services. The beneficial owners of the Applicant, TPG and Carlyle, have investment and management experience in the healthcare sector globally meaning the Applicant will be able to support Healthscope’s management to grow and develop Healthscope’s business. The overseas investment transaction has satisfied the criteria in section 18 of the Overseas Investment Act 2005. |
| More information | Pip England Chapman Tripp (Auckland) PO Box 2206 AUCKLAND 1140 |